Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anca Trifan

Showing results (171-180 of 215) with videos related to

Pageof 22
Sort By:
Life (Basel, Switzerland)|August 28, 2025
Reply to Scarlata, G.G.M.; Abenavoli, L. Comment on "Rotaru et al. Lean MASLD and IBD: Exploring the Intersection of Metabolic Dysfunction and the Gut-Liver Axis. <i>Life</i> 2025, <i>15</i>, 288"Adrian Rotaru, Remus Stafie, Ermina Stratina, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|March 16, 2021
Effectiveness of 8- and 12-Week Treatment with Ombitasvir/ Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve HCV Patients in a Real-Life Setting in Romania: the AMETHYST StudyAnca Trifan, Carol Stanciu, Laura Iliescu, et al.
Diagnostics (Basel, Switzerland)|April 23, 2022
Clinical and Laboratory Characteristics of Normal Weight and Obese Individuals with Non-Alcoholic Fatty Liver DiseaseAnca Trifan, Adrian Rotaru, Remus Stafie, et al.
Diagnostics (Basel, Switzerland)|July 27, 2022
Simultaneously Screening for Liver Steatosis and Fibrosis in Romanian Type 2 Diabetes Mellitus Patients Using Vibration-Controlled Transient Elastography with Controlled Attenuation ParameterAnca Trifan, Ermina Stratina, Robert Nastasa, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|December 19, 2022
Real World Efficacy and Safety of Sofosbuvir + Velpatasvir + Voxilaprevir in Romanian Patients with Genotype 1b HCV Infection Non-reponders to DAAs TherapyLiana Gheorghe, Carmen Preda, Anca Trifan, et al.
Molecules (Basel, Switzerland)|June 28, 2019
Duodenoscope-Associated Infections beyond the Elevator Channel: Alternative Causes for Difficult ReprocessingGheorghe G Balan, Irina Rosca, Elena-Laura Ursu, et al.
United European Gastroenterology Journal|March 12, 2026
Integrated Assessment of Intestinal Barrier Function and Microscopic Inflammation Using Confocal Laser Endomicroscopy for Relapse Prediction in Ulcerative ColitisHoria Minea, Catalin Sfarti, Stefan Chiriac, et al.
Hepatology Communications|January 24, 2023
High prevalence of liver fibrosis among general population: a Romanian population-based studyAnca Trifan, Cristina-Maria Muzica, Robert Nastasa, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|June 16, 2017
Position paper on treatment of hepatitis C in Romania, 2017. Part oneLiana Gheorghe, Ioan Sporea, Speranţa Iacob, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|December 24, 2015
Hepatitis Delta Virus Infection in Romania: Prevalence and Risk FactorsLiana Gheorghe, Irma Eva Csiki, Speranta Iacob, et al.
Pageof 22

Showing results (171-180 of 215) with videos related to

Sort By:
Pageof 22
Life (Basel, Switzerland)|August 28, 2025
Reply to Scarlata, G.G.M.; Abenavoli, L. Comment on "Rotaru et al. Lean MASLD and IBD: Exploring the Intersection of Metabolic Dysfunction and the Gut-Liver Axis. <i>Life</i> 2025, <i>15</i>, 288"Adrian Rotaru, Remus Stafie, Ermina Stratina, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|March 16, 2021
Effectiveness of 8- and 12-Week Treatment with Ombitasvir/ Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve HCV Patients in a Real-Life Setting in Romania: the AMETHYST StudyAnca Trifan, Carol Stanciu, Laura Iliescu, et al.
Diagnostics (Basel, Switzerland)|April 23, 2022
Clinical and Laboratory Characteristics of Normal Weight and Obese Individuals with Non-Alcoholic Fatty Liver DiseaseAnca Trifan, Adrian Rotaru, Remus Stafie, et al.
Diagnostics (Basel, Switzerland)|July 27, 2022
Simultaneously Screening for Liver Steatosis and Fibrosis in Romanian Type 2 Diabetes Mellitus Patients Using Vibration-Controlled Transient Elastography with Controlled Attenuation ParameterAnca Trifan, Ermina Stratina, Robert Nastasa, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|December 19, 2022
Real World Efficacy and Safety of Sofosbuvir + Velpatasvir + Voxilaprevir in Romanian Patients with Genotype 1b HCV Infection Non-reponders to DAAs TherapyLiana Gheorghe, Carmen Preda, Anca Trifan, et al.
Molecules (Basel, Switzerland)|June 28, 2019
Duodenoscope-Associated Infections beyond the Elevator Channel: Alternative Causes for Difficult ReprocessingGheorghe G Balan, Irina Rosca, Elena-Laura Ursu, et al.
United European Gastroenterology Journal|March 12, 2026
Integrated Assessment of Intestinal Barrier Function and Microscopic Inflammation Using Confocal Laser Endomicroscopy for Relapse Prediction in Ulcerative ColitisHoria Minea, Catalin Sfarti, Stefan Chiriac, et al.
Hepatology Communications|January 24, 2023
High prevalence of liver fibrosis among general population: a Romanian population-based studyAnca Trifan, Cristina-Maria Muzica, Robert Nastasa, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|June 16, 2017
Position paper on treatment of hepatitis C in Romania, 2017. Part oneLiana Gheorghe, Ioan Sporea, Speranţa Iacob, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|December 24, 2015
Hepatitis Delta Virus Infection in Romania: Prevalence and Risk FactorsLiana Gheorghe, Irma Eva Csiki, Speranta Iacob, et al.
Pageof 22